Peter DeYoung, CEO Piramal Global Pharma

Peter DeYoung is the CEO of Piramal Global Pharma and a member of the Piramal Pharma Operating Board. Piramal Global Pharma is comprised of Piramal Pharma Solutions and Piramal Critical Care business units. In his current role, Peter is responsible for steering strategy and driving profitable growth of these businesses.

Prior to this, he spearheaded several leadership roles within the Piramal Group, including CEO of Piramal Critical Care and President of Life Sciences.

Previously, Peter DeYoung worked in various investing and consulting roles in healthcare in the USA, Europe and India. He joined McKinsey & Company in New York after graduating from Princeton, where he worked several projects for pharmaceutical and medical device companies. He was then seconded by McKinsey to the World Economic Forum in Geneva, Switzerland as part of the Global Health Initiative. Peter DeYoung returned to McKinsey in New York and later in Mumbai, where he focused on the pharmaceutical and healthcare practice. Later, he joined the Blackstone Group’s Private Equity Division in Mumbai where he was part of the deal team for several significant transactions, across a wide spectrum of industry sectors in India.

Peter DeYoung holds a Master’s Degree in Business Administration from Stanford University (Arjay Miller Scholar), California, USA and a Bachelor’s of Science Degree in Engineering from Princeton University, New Jersey, USA, graduating summa cum laude.

Jeffrey Hampton, President & COO

Jeff Hampton serves as President and Chief Operating Officer (COO) of Piramal Critical Care (PCC), where he oversees the company’s Global Operations, Regulatory Affairs, Sales and Marketing, EHS, IT, Business and Product Development, and Program and Alliance Management functions. He is responsible for driving PCC’s global business by leading strategy development and growth initiatives, positioning the organization to increase market share within the industry, and building and maintaining relationships with Group Purchasing Organizations (GPOs), customers, channel partners, product developers, and manufacturers. (Possible wording changes for a slightly easier read).

Jeff’s expertise lies across global sales and marketing, commercial operations, and distribution strategies for pharmaceutical organizations. Prior to joining PCC, Jeffrey Hampton was the President at Accord Healthcare and was responsible for accelerating the firm’s growth strategy. Jeffrey has also held key positions at Apotex, Osmotica, Dabur and IVAX/Teva Pharmaceuticals.

Jeff holds a Bachelor of Science in Marketing from University of Florida and resides in North Carolina.

Rashida Najmi, Chief Quality Officer

Rashida Najmi is Chief Quality Officer at Piramal Critical Care. She is responsible for establishing and implementing related quality standards, handling inspections, and maintaining regulatory track records of various regulatory agencies such as FDA, MHRA, and PMD.

Rashida maintains decades of experience in quality management of NDA, INDA, CRO, API- intermediates, API (drug substance), various dosage formulations (drug product), product development, clinical, pharmacovigilance, and biologic, with renowned companies like Shreya Life Sciences and ACG. During Rashida’s ongoing tenure at Piramal, she has successfully maintained the compliance benchmark higher than the

regulatory requirement at all Pharma Solutions manufacturing sites across geographies. She is also instrumental in establishing ‘Quality’ as a differentiator for business growth and harmonizing “best in class” quality practices across Piramal.

Rashida is a Pharmacist and a postgraduate in Human Resources and is a Qualified Lead Auditor in ISO 9000 and ISO 14000 (from QMI, UK), certified in HACCP (from UN/ FAO), 5’S’ (from JMA), and OHSAS. In 2015, World Quality Congress awarded Rashida with the title of “50 Most Influential Quality Professionals.” She has been a jury member in several academic and quality awards and also an active member of industry forums like ISPE, IDMA, PDA, and OPPI.

Mahesh Sane, Sr. Vice President Finance

Mahesh Sane is the Sr. Vice President Finance at Piramal Critical Care. Mahesh is responsible for the finance function of Piramal Critical Care’s global business spread across the United States, Europe, and India.

An experienced finance professional with more than 20 years of manufacturing industry experience, Mahesh began his career with Cadbury’s, a global food company, in Mumbai. With a career of multiple promotions and expanding functional expertise, Mahesh has worked across various industries such as food, steel, textile, chemicals, and pharmaceuticals. In 2007, Mahesh joined Piramal Group as General Manager (Divisional Controller) responsible for finance functions of the vitamin business. Within one year of vitamin business turnaround,

Mahesh was promoted to manage the finance function of the Formulation Division of Piramal’s Contract Manufacturing business and in 2010 he took a new responsibility to lead the finance function of the Global Critical Care Business and relocated to the United States.

Throughout his career, Mahesh has been involved in providing strategic direction to business units and leading efforts to grow and turnaround businesses. His key contributions include strategic financial management and reporting, business unit re-engineering, budgeting and internal control, risk management, and banking relationships.

Mahesh earned his Master’s Degree in Commercefrom Mumbai University, a professional qualification in Cost Accounting from ICWA India, and acquired another professional qualification as Certified Chartered Accountant from ACCA in Glasgow, UK.

Sven Toms, Senior Vice President Commercial, EMEA & RoW

Sven Toms is the Senior Vice President of Commercial for EMEA and Rest of World at Piramal Critical Care. He leads the region’s commercial strategy, in-market execution, customer partnerships and P&L performance across Europe, the Middle East, Africa, Latin America, APAC, India, and China. Known for a performance-driven and purpose-led leadership style, he brings clarity, ambition, and momentum to teams, inspiring them to deliver exceptional results in complex and fast-moving markets.

With more than two decades of global experience across pharmaceuticals and consumer healthcare, Sven has held senior commercial and strategic roles in the United States, Europe, Australia, and emerging markets. His career reflects a strong track record of achieving results through disciplined execution and empowering people, shaped by leadership positions at Alliance Pharmaceuticals, Sandoz, GSK Consumer Healthcare, Pfizer, and Johnson & Johnson.

Sven holds a degree in Business & Engineering (Hons) from Sheffield Hallam University and has completed executive education at Harvard Business School. Having lived and led teams across three continents – North America, Europe, and Australia – he brings a global

perspective, strategic clarity and a commitment to developing high-performing teams that deliver meaningful impact.

Nick Dustman, Vice President North America Sales & Marketing

Nick is responsible for the sales and marketing function of Piramal Critical Care across North America.

Nick has shown a strong track record of progressive leadership within the pharmaceutical industry. He has extensive experience in the anesthetic inhaled agent and injectable market and has served as the Sr. Direct Sales for several brand and generic pharmaceutical companies. Nick has a proven track record of success showcased through leadership roles at several companies such as Abbott, Bioniche/Mylan, American H ealth Packaging, Ferring and Leucadia/Hikma.

Nick holds a Bachelor’s Degree in Business Administration from Pensacola Christian College in Florida, USA and currently resides in Florida.

Dr. Mark Aikman, Vice President Regulatory Affairs

Mark Aikman is a seasoned veteran of the pharmaceutical industry with over three decades of experience. After beginning his career as a practicing pharmacist in retail, hospital, and nursing home settings, he went back to school part-time to obtain his Doctorate of Pharmacy Degree (PharmD).

Mark Aikman has worked in a variety of roles over the years. While most of the time was spent in regulatory and quality roles, he also has spent a brief period in sales and marketing as the Managing Director of Kremers Urban where he was instrumental in the development of generic omeprazole, a blockbuster product for the US market.

Mark Aikman’s experience covers a large extent of regulatory pathways from NDAs, ANDAs, 505(b)(2)s, and 510Ks, as well as ex-US applications. He has been instrumental in the US development, approval, and commercialization of successful 505(b)(2) products and difficult generics. He also has a firm understanding of both clinical development and medical affairs in the pre-launch and post-commercial arenas.

Aksheta (Ash) Shetty Perera, Senior Director and Global Head PCC HR

Ash leads the global HR function for PCC and is responsible for shaping and delivering the organization’s people strategy across regions. She works to drive initiatives across culture, talent development, employee engagement, compensation, and workplace experience, ensuring strong alignment with business priorities and organizational growth.

Ash has played a key role in strengthening the global people agenda and fostering an inclusive, high-performance culture at Piramal Critical Care. She is passionate about creating an environment where employees feel valued, supported, and empowered to grow, contribute, and perform at their best.

Ash holds Master’s degrees in Human Resource Management and Business Psychology from the University of Manchester. She also holds a CIPD Level 7 Advanced Diploma in Strategic People Management, is a certified Mental Health First Aider from MHFA England, and a Certified Cognitive Behavioral Life Coach.

Hemant Kumar, Global Head of Supply Chain

Hemant Kumar is an accomplished Supply Chain and Operations leader with over 30 years of experience in the global pharmaceutical industry. A Production Engineer with an MBA in Operations Management from Mumbai University, Hemant began his career in the steel industry before earning admission to one of India’s premier management institutes. On Day One of campus placements, he was selected as a Management Trainee by Ranbaxy Laboratories—then one of India’s top pharmaceutical companies—marking the start of a remarkable professional journey.

Over the course of his career, Hemant has accumulated decades of leadership experience across renowned organizations including Ranbaxy, Sun Pharma, Mylan (now Viatris), Glenmark, Cadila, and currently Piramal Critical Care. His tenure at Ranbaxy was particularly transformative, as he progressed from a fresh management trainee in a $100M organization to leading the global end-to-end supply chain for what had grown into a $2.3B enterprise.

Hemant’s expertise spans the entire supply chain landscape, including demand and supply planning, global logistics, India distribution, procurement, lifecycle management, third-party/CMO management, launch management, and project management. He has also played a pivotal role in numerous Business Process Reengineering (BPR) initiatives in partnership with top global consulting firms such as Accenture, Bristlecone, McKinsey, BCG, EY, PwC, and Vector Consulting. His contributions have been central to major system transformations involving SAP, MRP, APO, S&OP, and PPDS.

A particularly enriching chapter of his career was his three-year tenure with the Chairman & Managing Director’s Office, where he contributed to global strategy formulation and execution of high-impact strategic projects.

Hemant currently serves as the Global Head of Supply Chain at Piramal Critical CareHe is focused on strengthening systems and processes, driving long-range planning objectives, and leading a successful S/4HANA implementation to enhance global operational excellence.

Rajendra Mali, Manufacturing at Piramal Critical Care (PCC)

In this role, Rajendra oversees manufacturing and API R&D operations across India and the US API sites, including Packaging Technology and Serialization operations.

Rajendra brings significant experience in the API and pharmaceutical industry, with extensive expertise in plant operations, manufacturing, process engineering, capital projects, and operational excellence. Prior to joining Piramal, he worked with Ciba, Dr. Reddy’s Laboratories, and Shasun, where he held roles in Research & Technology, Technical Services, Process Engineering, and Capital Projects.

In 2007, Rajendra joined the Piramal Group as Chief Manager (Manufacturing), where he was responsible for the manufacturing operations of the Anesthetic business. After successfully stabilizing the anesthetic manufacturing operations, he played a key role in the

backward integration of intermediates for Sevoflurane and Isoflurane and led the establishment of the Dahej site to ensure uninterrupted supply of critical intermediates for both APIs.

Over the years, he has led the development of several greenfield and brownfield projects globally and has been instrumental in revamping and upgrading facilities across geographies to meet global quality and regulatory standards at Piramal Pharma.

Rajendra holds a Bachelor’s Degree in Chemical Engineering from the Institute of Chemical Technology formerly known as UDCT, Mumbai, India.

Radhakrishnan B, Vice President – Strategy, Business Development, and Strategic Alliances

Radhakrishnan B. is Vice President – Strategy, Business Development and Strategic Alliances, based in Mumbai, India, where he is responsible for driving growth through strategic partnerships, in licensing / acquisition opportunities, and commercialization initiatives across global markets. He works closely with internal and external stakeholders to identify and execute opportunities that strengthen the company’s portfolio and market presence.

Prior to his current role, Radha worked with PwC in the management consulting practice, advising pharmaceutical, biotechnology, and CDMO clients on portfolio strategy, market entry, acquisition and partnership opportunities, operating model design, and value capture initiatives across growth and transformation programs. Earlier, he held operations strategy roles at Dr. Reddy’s Laboratories, where he supported initiatives focused on network strategy, manufacturing efficiency, and aligning operational capabilities with long term product and market strategies.

Radhakrishnan holds an MBA from the Symbiosis Centre for Management and Human Resource Development (SCMHRD), Pune, and a B.Tech from the College of Engineering, Trivandrum.